Navigation Links
Pivotal Registration Trial of OPAXIO Maintenance Therapy in First-Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients, Cell Therapeutics and the Gynecologic Oncology Group Discuss Potential for Early Interim Analysis
Date:9/21/2009

ation pathway for OPAXIO."

"We believe focusing on ovarian maintenance, and radiosensitization, not only address areas of unmet medical need, but are in the best long term strategic interest of CTI. With the FDA review of the NDA for pixantrone in relapsed/refractory non-Hodgkin's lymphoma well underway and the phase III Ovarian trial of OPAXIO progressing nicely we are pleased with the advancement and future potential of these novel treatments," said James A. Bianco, M.D., CEO of CTI.

CTI has an existing license and co-development agreement with Novartis for OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which also provides Novartis with an option to enter into an exclusive worldwide license to develop and commercialize pixantrone based upon agreed terms.

About OPAXIO

OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was formerly known as XYOTAX(TM), is an investigational, biologically enhanced, chemotherapeutic that links paclitaxel, the active ingredient in Taxol(R), to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, the chemotherapy is rendered inactive, potentially sparing normal tissue's exposure to high levels of unbound, active chemotherapy and its associated toxicities. Blood vessels in tumor tissue, unlike blood vessels in normal tissue, are porous to molecules like polyglutamate. Based on preclinical studies, it appears that OPAXIO is preferentially distributed to tumors due to their leaky blood vessels and trapped in the tumor bed allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard paclitaxel. Once inside the tumor cell, enzymes metabolize the protein polymer, releasing the paclitaxel chemotherapy.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncol
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Cardiac Dimensions ... data from the TITAN II clinical trial of ... and sustained improvements in mitral regurgitation, functional improvement, ... long-term safety and efficacy data, which was consistent ... Sept. 13 at the 26 th annual ...
(Date:9/17/2014)... 17, 2014  Neuraltus Pharmaceuticals, Inc. announced today that ... program of NP001 for the treatment of amyotrophic lateral ... being highlighted today in an oral presentation at the ... being held in Bloomington, Minnesota , ... administration of a high dose of NP001 (2mg/kg) was ...
(Date:9/17/2014)... and MILL VALLEY, Calif. ... Sarcoma Alliance today announced a partnership in the ... will sponsor the Sarcoma Alliance Suzanne Renee Leider ... program offers financial assistance to reimburse sarcoma patients ... opinion from a sarcoma specialist. Scientific literature reinforces ...
Breaking Medicine Technology:Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3
... 31, 2011 Luminex Corporation (Nasdaq: LMNX ... Jefferies 2011 Global Healthcare Conference to be held June ... ) The investor presentation by Patrick ... at 9:00 a.m. Eastern time on Tuesday, June 7, 2011. ...
... 2011 The Procter & Gamble Company (NYSE: ... its U.S. Sustainability Expert Advisory Panel (SEAP). The new members ... Manager, Clinton Global Initiative Dr. Howard Frumkin – Dean, ... Terry Tamminen – Former Secretary, California Environmental Protection Agency ...
Cached Medicine Technology:Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference 2P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 2P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 3
(Date:9/18/2014)... Forty Fort, PA (PRWEB) September 18, 2014 ... remodeling display at the Bloomsburg Fair beginning this Saturday. ... The display is a great example of the products and ... three cabinet lines and various countertops for fair-goers to see. ... Home & Garden Show earlier this year and really is ...
(Date:9/18/2014)... 18, 2014 For many people, tomato soup ... online food delivery service provider, gives it a new stir—in ... Basil soup is a nod to this culinary classic—with a ... tangy tomato base, then Spoonful of Comfort's chefs stir in ... flashback to childhood has never tasted better. , Founder, ...
(Date:9/18/2014)... With the development of China’s ... adjusting human body physiology, preventing diseases, promoting health, ... a variety of specific populations. In 2013, the ... RMB187.4 billion, up 12.0% year on year, recording ... Full Report at http://www.marketresearchreports.biz/analysis/223449 , China's ...
(Date:9/18/2014)... Atlanta, GA (PRWEB) September 18, 2014 ... Counselor, recognizes that 1- sometimes, inner beauty has to ... strengths have to be acknowledged in order to be ... , Healing Hearts shows the world how to do ... Counseling and Life Coaching using the Healing Hearts system, ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 N-Zyme Scientifics ... successfully launching its first product a mere 8 months ... is a high performance glycan release enzyme used in ... research, and the basis for tissue pathology on Mass ... (Portsmouth, NH) for the North American market (PNGase F ...
Breaking Medicine News(10 mins):Health News:One Week Kitchens Taking Display to Bloomsburg Fair 2Health News:An Old Classic Brings New Soup Delivery Options to Spoonful of Comfort 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 3Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 4Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3Health News:N-Zyme Scientifics Announces Successful Product Launch 2
... Neurologists at the University at Buffalo are beginning a ... the cause of multiple sclerosis (MS). The researchers will ... from narrowing of the primary veins outside the skull, ... CCSVI is a complex vascular condition discovered ...
... Study shows ways to optimize hand movements , FRIDAY, Oct. ... make it easier for people with multiple sclerosis to pick ... with MS use excessive force when lifting objects, which can ... from the University of Illinois at Chicago explained in a ...
... 29th October is "What can I do?". As the World ... symptoms and take action, learn to recognise the risk factors ... the European Society of Cardiology (ESC) emphasises that most of ... coronary heart disease - and thus the object of the ...
... to behavior dictated by society in which they live, researchers ... wide varieties of culture that differ from nation to nation, ... a new study suggests that chimpanzees have their own form ... found that chimpanzee populations that live next to each other ...
... relieves pain as well as seven-day regimen, researchers find , ... antibiotics may be as effective as a seven-day course in ... study has found. , The study appears in the October ... Neck Surgery . , Pain after a tonsillectomy can make ...
... and a possible death,toll into the millions, UC Davis ... diseases that move between,wildlife and people. The global ... of up to $75 million over five years and ... for International Development,(USAID) known in combination as the Emerging ...
Cached Medicine News:Health News:Buffalo neurologists investigate possible new underlying cause of MS 2Health News:Buffalo neurologists investigate possible new underlying cause of MS 3Health News:Buffalo neurologists investigate possible new underlying cause of MS 4Health News:Light Touch Helps Grip of MS Patients 2Health News:Learning the risks for stroke -- and taking action 2Health News:Learning the risks for stroke -- and taking action 3Health News:Chimps Show Signs of Culture 2Health News:After Tonsillectomy, Short-Term Antibiotics Effective: Study 2Health News:UC Davis leads attack on deadly new diseases 2Health News:UC Davis leads attack on deadly new diseases 3
... Swing doors, 8 shelves. Over-sized ... doors. Fluorescent interior lighting. Self-Contained System ... foot cord. Full One Year Warranty on ... Warranty on Compressor. Also available as ...
... Independent controls for Digital Thermostat and Digital ... steel. , Interiorwhite anodized aluminum with ... Oversized refrigeration (134A). , Temperature range ... self-closing doors. , Foamed-in-place polyurethane high ...
... The HC Series Large Capacity Refigerators ... embryos, semen, or biological samples at liquid-nitrogen ... holding times and capacities are available to ... Two low profile HCL models are also ...
... refrigerators from Taylor-Wharton are uniquely designed to ... box-type storage racks and the lower operating ... The RackSystems are available in four convenient ... 750 x 2ml vials to 4800 x ...
Medicine Products: